AV
RMD icon

ASR Vermogensbeheer’s ResMed RMD Stock Holding History

ASR Vermogensbeheer’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Sell
11,290
-1,539
-12% -$319K 0.02% 351
2026
Q1 		$2.88M Buy
12,829
+260
+2% +$64.8K 0.03% 322
2025
Q4 		$3.03M Sell
12,569
-130
-1% -$33.2K 0.04% 312
2025
Q3 		$3.48M Sell
12,699
-97
-0.8% -$26.5K 0.04% 301
2025
Q2 		$3.3M Buy
12,796
+542
+4% +$129K 0.04% 299
2025
Q1 		$2.74M Buy
+12,254
New +$2.86M 0.04% 297

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

ASR Vermogensbeheer's RMD Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its ResMed (RMD) stake by 12% in Q2 2026, selling an estimated $319K and leaving 11,290 shares worth $2.2M. The position accounts for 0.02% of the portfolio, ranked #351.

ASR Vermogensbeheer first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.48M in Q3 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • ASR Vermogensbeheer held 11,290 shares of ResMed worth $2.2M as of Q2 2026.
  • ASR Vermogensbeheer sold 1,539 ResMed shares in Q2 2026, an estimated $319K.
  • ResMed made up 0.02% of ASR Vermogensbeheer's portfolio in Q2 2026, its #351 holding.
  • ASR Vermogensbeheer first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's ResMed position peaked at $3.48M in Q3 2025.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.